Microbot Medical
MBOT
27 hedge funds and large institutions have $4.65M invested in Microbot Medical in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 5 closing their positions.
52% more capital inflows, than outflows
Capital inflows: $376K | Capital outflows: $247K
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
0% more funds holding
Funds holding: 27 → 27 (0)
1.01% less ownership
Funds ownership: 11.43% → 10.43% (-1%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$87K |
| 2 |
Millennium Management
New York
|
+$82K |
| 3 |
Blueshift Asset Management
Red Bank,
New Jersey
|
+$75.2K |
| 4 |
Cetera Advisor Networks
El Segundo,
California
|
+$72.9K |
| 5 |
Renaissance Technologies
New York
|
+$31.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$95K |
| 2 |
Investment Management Associates
Greenwood Village,
Colorado
|
-$75K |
| 3 |
State Street
Boston,
Massachusetts
|
-$55.7K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8.49K |
| 5 |
BlackRock
New York
|
-$5.63K |
MBOT Hedge Fund Activity: Q1 2022 in Review
27 of the 6,365 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2022, worth a combined $4.65M — down 24% from $6.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBOT positions and 5 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $87K. The largest seller was Virtu Financial, exiting entirely with an estimated $95K sold.
- 27 institutional investors held Microbot Medical (MBOT) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $4.65M of Microbot Medical stock for Q1 2022, down 24% quarter-over-quarter.
- 6 funds opened new Microbot Medical positions in Q1 2022 and 5 closed out, a net change of +1 holder.
- The largest Microbot Medical buyer in Q1 2022 was Citadel Advisors, an estimated $87K added.
- The largest Microbot Medical seller in Q1 2022 was Virtu Financial, an estimated $95K sold.
Based on aggregated 13F filings for Q1 2022.